Charlie Chon

Charles Chon is a Partner and Managing Director of Ally Bridge Group. Mr. Chon leads ABG’s Medical Technologies effort and is a member of ABG’s Investment Committee. Before joining ABG in 2013, Mr. Chon had been a healthcare public equity research analyst for over 13 years on both buy-side and sell-side, mostly as Vice President and senior equity research analyst at Goldman Sachs on the US medical devices team. From there, Mr. Chon became the Sector Head for US medical devices research at Stifel Nicolaus. Mr. Chon began his career on Wall Street at ABN AMRO and also covered the healthcare sector from the buy-side at Fred Alger Management. Mr. Chon holds CFA designation, and received his MBA in healthcare management from Boston University and BA in Chemistry from Amherst College.